ExaCare AI

Post-acute admissions is a paperwork bottleneck. A nursing home receives a referral as an unstructured packet — often by fax — and someone has to read it, decide whether the facility can safely take the patient, and answer before a competitor does. ExaCare AI collapses that: it pulls referrals from hospital portals, referral platforms and eFax into a single inbox, reads the full clinical documentation against the facility's own admission criteria, and surfaces the risks and deal-breakers rather than leaving them buried. Laird Russell co-founded the company in 2022. He had played Division I hockey at Brown University until repeated traumatic brain injuries ended it, and spent three and a half years navigating medical care afterwards — the experience he credits for seeing where the delays actually sit. He had previously co-founded Galea Health, a mental-health platform for athletes, and worked at Goldman Sachs and Bain. ExaCare raised $6.5 million in early 2024 and a $30 million Series A in October 2025 led by Insight Partners, with Foundation Capital and Bienville Capital. It says it now serves more than 1,500 facilities. Russell spoke at TechTO's Health Toronto in November 2025.